Canopy Growth Corporation(TSX:WEED) (NASDAQ:CGC) announced its financial results on Friday for the third quarter ended Dec. 31, 2023, reporting an 81% year-over-year increase in "rest-of-world" cannabis revenue to CA$10.5 million ($7.8 million).

The Ontario, Canada-based medical cannabis giant attributed the increase in international cannabis revenue mostly to continued strong growth in Australia and a return to growth in Europe driven by new products and improved sales execution.

See also: These 2 Canadian Cannabis Companies Forge Ahead In European Markets With German, Dutch Ventures

Canopy also revealed its plans to take its fair share of the U.S...